Terray Therapeutics Announces Investment from NVIDIA to Enab

Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery

/PRNewswire/ -- Terray Therapeutics, a biotechnology company integrating scale experimentation and generative AI to improve the speed, cost, and success rate...

Related Keywords

Bassil Dahiyat , Mohamed Sid Siddeek , John Maraganore , Nvidia , Alnylam Pharmaceuticals , Chief Executive Officer , Jacob Berlin , Terray Therapeutics ,